Sarcoma News and Research

RSS
FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

FDA accepts Blueprint Medicines' IND applications to start Phase 1 clinical trials for two drug candidates

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award

Four young scientists named recipients of Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award

New research identifies potential treatment for primary effusion lymphoma

New research identifies potential treatment for primary effusion lymphoma

New therapeutic alternative found for children suffering from Ewing's sarcoma

New therapeutic alternative found for children suffering from Ewing's sarcoma

Pazopanib improves survival in soft tissue sarcoma patients without impairment of health-related quality of life

Pazopanib improves survival in soft tissue sarcoma patients without impairment of health-related quality of life

Damon Runyon creates new award to increase number of physician-scientists

Damon Runyon creates new award to increase number of physician-scientists

Dr. Maurizio D'Incalci to receive Pezcoller-Prodi Award in Scientific Career

Dr. Maurizio D'Incalci to receive Pezcoller-Prodi Award in Scientific Career

Phase II clinical trial of Linsitinib launched in patients with advanced Ewing sarcoma

Phase II clinical trial of Linsitinib launched in patients with advanced Ewing sarcoma

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

CASI files application with CFDA to conduct ENMD-2076 Phase 2 trial in fibrolamellar carcinoma patients

NW Bio releases promising new data on DCVax-Direct Phase I trial for inoperable solid tumors

NW Bio releases promising new data on DCVax-Direct Phase I trial for inoperable solid tumors

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

Adaptimmune presents clinical results of NY-ESO TCR therapeutic candidate at ASCO 2015

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

Trabectedin may be better than dacarbazine for treatment of soft tissue sarcoma

PharmaEngine files NDA with Taiwan FDA for MM-398 to treat post-gemcitabine metastatic pancreatic cancer

PharmaEngine files NDA with Taiwan FDA for MM-398 to treat post-gemcitabine metastatic pancreatic cancer

Modified cold sore (herpes) virus improves survival in stage IIIb to IV melanoma patients

Modified cold sore (herpes) virus improves survival in stage IIIb to IV melanoma patients

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Eisai Phase 3 trial of eribulin meets primary endpoint in patients with advanced soft tissue sarcoma

Modified herpes virus improves survival in melanoma patients

Modified herpes virus improves survival in melanoma patients

Neurosurgeon performs first endoscopic removal of spinal tumor at Rhode Island Hospital

Neurosurgeon performs first endoscopic removal of spinal tumor at Rhode Island Hospital

New genetic models allow for comprehensive analysis of drivers for osteosarcoma

New genetic models allow for comprehensive analysis of drivers for osteosarcoma

Positive clinical data of CytRx's aldoxorubicin to be presented at ASCO 2015

Positive clinical data of CytRx's aldoxorubicin to be presented at ASCO 2015

Johns Hopkins scientists safely use immune cells to treat multiple myeloma

Johns Hopkins scientists safely use immune cells to treat multiple myeloma